Stockholder's Equity (Tables)

12 Months Ended

Jul. 31, 2025

Equity [Abstract]

Schedule of Stock-Based Compensation

The table below sets forth the stock-based compensation recognized by the Company for stock options, restricted stock, restricted unit awards, and performance stock units:

	Year Ended July 31,
(In thousands)	2025		2024		2023
General and administrative	$	29,897	$	28,284	$	32,747
Facility operations	8,107		6,950		6,926
Total stock-based compensation	$	38,004	$	35,234	$	39,673

Schedule of BSM Option-Pricing Model

The BSM option-pricing model utilized the following assumptions:

	July 31,
	2025						2024						2023
Expected life (in years)	5.0			—	5.7		5.0			—	6.3		5.0			—	6.3
Risk-free interest rate	3.5		%	—	4.03	%	3.86		%	—	4.43	%	3.67		%	—	3.88	%
Estimated volatility	29.6		%	—	30.3	%	30.1		%	—	30.6	%	29.6		%	—	32.0	%
Expected dividends	—					%	—					%	—					%
Weighted average fair value at measurement date	$	20.58					$	9.93					$	12.10

Schedule of Unvested Stock Options Awards and Activity

A summary of the status of the Company’s unvested stock options awards and activity during the year ended July 31, 2025 was as follows:

(In thousands, except per share amounts)	Shares	Weighted Average Grant- date Fair Value
Unvested shares at July 31, 2024	4,178	$	9.80
Grants of non-vested shares	159	20.58
Vested	(2,226)	10.73
Forfeitures or expirations	(22)	1.03
Unvested shares at July 31, 2025	2,089	$	14.30

Schedule of Activity of Stock Options

The following is a summary of activity for the Company’s stock options for the year ended July 31, 2025:

(In thousands, except per share and term data)	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In years)	Aggregate Intrinsic Value
Outstanding as of July 31, 2024	16,310	$	18.60	4.34	$	550,115
Grants of options	159	58.34
Exercises	(3,961)	10.79
Forfeitures or expirations	(21)	4.41
Outstanding as of July 31, 2025	12,487	$	21.61	3.87	$	302,750
Exercisable as of July 31, 2025	11,069	$	19.21	3.42	$	291,821
Vested and expected to vest as of July 31, 2025	12,481	$	21.61	3.87	$	302,636

The following is a summary of activity for the Company’s stock option awards subject to market conditions for the year ended July 31, 2025:

(In thousands, except per share and term data)	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In years)	Aggregate Intrinsic Value
Outstanding as of July 31, 2024	5,995	$	24.70	6.47	$	165,656
Grants of options	—	—
Exercises	—	—
Forfeitures or expirations	—	—
Outstanding as of July 31, 2025	5,995	$	24.70	5.47	$	124,108
Exercisable as of July 31, 2025	5,302	$	23.64	5.28	$	115,169
Vested and expected to vest as of July 31, 2025	5,994	$	24.70	5.47	$	124,085

Schedule of Stock Options Outstanding and Exercisable

The following table summarizes stock options outstanding and exercisable as of July 31, 2025:

(In thousands, except per share amounts)			Options Outstanding				Options Exercisable
Range of Exercise Prices			Number	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number	Weighted Average Exercise Price
$4.76	—	$8.7	1,876	1.59	$	7.43	1,876	$	7.43
$9.08	—	$11.80	1,885	2.05	9.85		1,885	9.85
$14.57	—	$31.22	9,938	4.32	20.79		9,613	20.58
$31.42	—	$62.08	4,783	6.54	37.38		2,997	35.91
Outstanding as of July 31, 2025			18,482	4.39	$	22.61	16,371	$	20.65

Schedule of Activity for RSA’s, RSU’s and PSU’s

The following is a summary of activity for the Company’s RSAs, RSUs, ans PSUs for the for the year ended July 31, 2025:

(In thousands, except per share data)	Restricted and Performance Shares	Weighted Average Grant Date Fair Value
Outstanding as of July 31, 2024	1,873	$	47.29
Grants	250	51.51
Vested	(318)	39.99
Forfeitures or expirations	(27)	45.18
Outstanding as of July 31, 2025	1,778	$	48.93